x

Society

ANA: Canada’s Aphria Planning Medicinal Cannabis Investment in Xanthi

March 3, 2018
ANA

The Canadian firm Aphria is planning to launch an investment for the cultivation and production of medicinal in northeastern Greek region of Xanthi within 2018, Athens-Macedonian News Agency (ANA) sources said on Wednesday.

Representatives of the company had another meeting with Deputy Economy and Development Minister Stergios Pitsiorlas on Wednesday to discuss the planned investment, on a 5,000-hectare property, which is forecast to pump one billion euros into the Greek economy and create 450-500 jobs, the sources said.

The company is apparently hoping that the necessary procedures and joint ministerial decisions will be signed as soon as possible so that it can launch the investment before the end of the current year.

Aphria is a Canadian listed company that specialises in the production of industrial and medicinal cannabis and has operations in the United States, Canada and Germany.

RELATED

For those interested in All Things Royal, reports are that Princess Tatiana will still be called that after he divorce from Prince Nikolaos, although the monarchy was long ago abolished and neither have any real standing in the country apart from celebrity.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Over 100 Pilot Whales Beached on Western Australian Coast Have Been Rescued, Officials Say

MELBOURNE, Australia (AP) — More than 100 long-finned pilot whales that beached on the western Australian coast Thursday have returned to sea, while 29 died on the shore, officials said.

On Monday, April 22, 2024, history was being written in a Manhattan courtroom.

PARIS - With heavy security set for the 2024 Paris Olympic Games during a time of terrorism, France has asked to use a Greek air defense system as well although talks are said to have been going on for months.

WASHINGTON (AP) — A tiny Philip Morris product called Zyn has been making big headlines, sparking debate about whether new nicotine-based alternatives intended for adults may be catching on with underage teens and adolescents.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.